Stay updated on Zephyrus II Pamrevlumab Clinical Trial
Sign up to get notified when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.

Latest updates to the Zephyrus II Pamrevlumab Clinical Trial page
- Check2 days agoChange DetectedSponsor changed from FibroGen to Kyntra Bio in the study record.SummaryDifference0.3%

- Check9 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3; this is a minor site update and does not modify study data, endpoints, eligibility criteria, or recruitment information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer updated from Revision: v3.3.1 to Revision: v3.3.2, with no visible changes to the main content or features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 as the page version, with no changes to study details, eligibility criteria, outcomes, or recruitment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe notice about government funding-related operating status was removed from the page. This removes guidance that updates may be delayed or information not up to date pending appropriations.SummaryDifference0.4%

Stay in the know with updates to Zephyrus II Pamrevlumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.